EssexBio

Essex-Bio Group

简繁 EN

ANNOUNCEMENTS & SHAREHOLDER INFORMATION

Normative Disclosure, Honest Communication

Date

Title

File

Times

2021-03-24

NEXT DAY DISCLOSURE RETURN

1611

2021-03-23

NEXT DAY DISCLOSURE RETURN

1628

2021-03-19

VOLUNTARY ANNOUNCEMENT FURTHER UPDATE IN RELATION TO THE CO-DEVELOPMENT OF THE LICENSED PRODUCT WITH HENLIUS RELATING TO THE TREATMENT OF EXUDATIVE (WET) AGE-RELATED MACULAR DEGENERATION

1577

2021-03-12

ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2020

1805

2021-03-02

NOTICE OF BOARD MEETING

1574

2021-03-02

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2021

1600

2021-03-01

CHANGE OF ADDRESS OF PRINCIPAL SHARE REGISTRAR AND TRANSFER AGENT IN THE CAYMAN ISLANDS

1523

2021-02-24

INSIDE INFORMATION FURTHER UPDATES IN RELATION TO CO-DEVELOPMENT AGREEMENT - POSITIVE OUTCOME OF U.S. FDA SECOND PHASE 3 CLINICAL TRIAL IN DRY EYE DISEASE

1589

2021-02-22

NSIDE INFORMATION FURTHER UPDATES IN RELATION TO CO-DEVELOPMENT AGREEMENT - U.S. FDA SECOND PHASE 3 CLINICAL TRIAL ("VISTA-2") IN DRY EYE DISEASE

1582

2021-02-22

NEXT DAY DISCLOSURE RETURN

1727

2021-02-02

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2021

1647

2021-01-29

VOLUNTARY ANNOUNCEMENT UPDATE IN RELATION TO THE CO-DEVELOPMENT OF THE LICENSED PRODUCT WITH HENLIUS RELATING TO THE TREATMENT OF EXUDATIVE (WET) AGE-RELATED MACULAR DEGENERATION

1702

2021-01-29

NEXT DAY DISCLOSURE RETURN

1675

2021-01-28

NEXT DAY DISCLOSURE RETURN

1617

2021-01-27

NEXT DAY DISCLOSURE RETURN

1672

2021-01-26

NEXT DAY DISCLOSURE RETURN

1711

2021-01-22

NEXT DAY DISCLOSURE RETURN

1663

2021-01-20

NEXT DAY DISCLOSURE RETURN

1714

2021-01-19

NEXT DAY DISCLOSURE RETURN

1598

2021-01-18

NEXT DAY DISCLOSURE RETURN

1657

This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.

ACCEPT